X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

Alternative Venture Capital: The New Unicorn Investors

In a new paper, Alternative Venture Capital: The New Unicorn Investors, professor Anat Alon-Beck exp...

Read More >

The Legend of the Korean Fish Store

I grew up in Brooklyn and the area I originally lived in is called Midwood and I lived right off a s...

Read More >

[Audio] CEQA Streamlining for Transportation Projects

The California Environmental Quality Act (CEQA) requires state and local government agencies to iden...

Read More >

Defence + Indemnity - August 2019: Case Summary: Goddard v Bayside Property Services Ltd

The British Columbia Court of Appeal held that a plaintiff can establish liability in an occupiers’...

Read More >

InterConnect FLASH! No 77: California AB5 Litigation Update - The TRO is Extended

Yesterday, on January 13, 2020, Judge Benitez of the United States District Court for the Southern D...

Read More >

M&A Deals and PPP Loans: Unexpected Parties in Your Deal

The Payroll Protection Program has been a lifesaver to many businesses this year, but its quick roll...

Read More >